• SPX
  • 5969.34
  • 0.35 %
  • 20.6299
  • DJI
  • 44296.51
  • 0.97 %
  • 426.1133
  • N225
  • 38780.14
  • 1.3 %
  • 496.2891
  • FTSE
  • 8291.61
  • 0.36 %
  • 29.53
  • IXIC
  • 19003.65
  • 0.16 %
  • 31.25
TransMedics Group, Inc. (TMDX) Stock Price, News & Analysis

TransMedics Group, Inc. (TMDX) Stock Price, News & Analysis

Currency in USD Disclaimer

$76.12

-$3.22

(-4.06%)

Day's range
$72.95
Day's range
$76.87
50-day range
$72.68
Day's range
$169.29
  • Country: US
  • ISIN: US89377M1099
52 wk range
$67.77
Day's range
$177.37
  • CEO: Dr. Waleed H. Hassanein M.D.
  • Website: Visit Site


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score 3.12
  • Piotroski Score 5.00
  • Grade Buy
  • Symbol (TMDX)
  • Company TransMedics Group, Inc.
  • Price $76.12
  • Changes Percentage (-4.06%)
  • Change -$3.22
  • Day Low $72.95
  • Day High $76.87
  • Year High $177.37

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 02/24/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $135.00
  • High Stock Price Target $180.00
  • Low Stock Price Target $45.00
  • Potential Upside/Downside N/A
  • Consensus Rating Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$0.35
  • Trailing P/E Ratio -391.94
  • Forward P/E Ratio -391.94
  • P/E Growth -391.94
  • Net Income $-25,028,000

Income Statement

Quarterly

Annual

Latest News of TMDX

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

TransMedics Group, Inc. Frequently Asked Questions

  • What is the TransMedics Group, Inc. stock price today?

    Today's price of TransMedics Group, Inc. is $76.12 — it has decreased by -4.06% in the past 24 hours. Watch TransMedics Group, Inc. stock price performance more closely on the chart.

  • Does TransMedics Group, Inc. release reports?

    Yes, you can track TransMedics Group, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the TransMedics Group, Inc. stock forecast?

    Watch the TransMedics Group, Inc. chart and read a more detailed TransMedics Group, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is TransMedics Group, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by TransMedics Group, Inc. stock ticker.

  • How to buy TransMedics Group, Inc. stocks?

    Like other stocks, TMDX shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is TransMedics Group, Inc.'s EBITDA?

    TransMedics Group, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in TransMedics Group, Inc.’s financial statements.

  • What is the TransMedics Group, Inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is -0.1035828543, which equates to approximately -10.36%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in TransMedics Group, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including TransMedics Group, Inc.'s financials relevant news, and technical analysis. TransMedics Group, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for TransMedics Group, Inc. stock currently indicates a “sell” signal. For more insights, review TransMedics Group, Inc.’s technical analysis.

  • A revenue figure for TransMedics Group, Inc. for its last quarter?

    TransMedics Group, Inc. published it's last quarterly revenues at $108.76 M.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.